Cardiovascular disease and chronic kidney disease: From treatment to promoting health;Enfermedades cardiovasculares y nefropatía crónica: del tratamiento al fomento de la salud

Medicina Clinica

Volumn 132, Issue SUPPL. 1, 2009, Pages 33-37

  Van Der Zee, S ^a   Fuster, V ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular risk factors; Chronic kidney disease

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BLOOD STORAGE; BODY MASS; CANCER SCREENING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET; EXERCISE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERTENSION; INFECTION; KIDNEY CALCIFICATION; KIDNEY FAILURE; MICROALBUMINURIA; PROTEINURIA; SMOKING; THROMBOSIS; UNITED NATIONS;

CARDIOVASCULAR DISEASES; HEALTH PROMOTION; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 67649233447     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/S0025-7753(09)70960-1     Document Type: Article

References (38)

1. A.S. Levey, J. Coresh, T. Greene, J. Marsh, L.A. Stevens, Y.L. Zhang Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine valves in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med. 145 4 2006 Aug 15. 274-54
2. P.A. McCullough, C.T. Jurkovitz, P.E. Pergola, J.B. McGill, W.W. Brown, and A.J. Collins Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP) Arch Intern Med 167 2007 1122 1129 (Pubitemid 46919814)
3. J.A. Vassalotti, L.A. Stevens, and A.S. Levey Testing for chronic kidney disease: a position statement from the National Kidney Foundation Am J Kidney Dis 50 2007 169 180 (Pubitemid 47095094)
4. M.J. Lysaght Maintenance dialysis population dynamics: current trends and long-term implications J Am Soc Nephrol 13 Suppl 1 2002 S37 S40
5. F.C. Brosius 3rd, T.H. Hostetter, E. Kelepouris, M.M. Mitsnefes, S.M. Moe, and M.A. Moore Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils On High Blood Pressure Research, Cardiovascular Disease In The Young, and Epidemiology And Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation Circulation 114 2006 1083 1087 (Pubitemid 44358886)
6. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and risk of death, cardiovascular events and hospitalization N Engl J Med 351 2004 1296 1305
7. D.E. Weiner, H. Tighiouart, M.G. Amin, P.C. Stark, B. MacLeod, and J.L. Griffith Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315 (Pubitemid 38526012)
8. E.F. Elsayed, H. Tighiouart, J. Griffith, T. Kurth, A.S. Levey, and D. Salem Cardiovascular disease and subsequent kidney disease Arch Intern Med 167 2007 1130 1136 (Pubitemid 46919815)
9. J.A. Breyer, R. Bain, J.K. Evans, N.S. Nahman, and E.J. Lewis Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group Kidney Int 50 1996 1651 1658 (Pubitemid 26364271)
10. G. Remuzzi, A. Benigni, and A. Remuzzi Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes J Clin Invest 116 2006 288 296 (Pubitemid 43228342)
11. El. Meguid, A. Nahas, and A.K. Bello Chronic kidney disease: the global challenge Lancet 365 2005 331 340 (Pubitemid 40139112)
12. M.G. Shlipak, L.F. Fried, M. Cushman, T.A. Manolio, D. Peterson, and C. Stehman-Breen Cardiovascular mortality risk in chronic kidney disease: comparision of traditional and novel risk factors JAMA 293 2005 1737 1745
13. V. Fuster, and J. Voute MDGs: chronic diseases are not on the agenda Lancet 366 2005 1512 1514 (Pubitemid 41540101)
14. J.A. Martin, H.C. Kung, T.J. Mathews, D.L. Hoyert, D.M. Strobino, and B. Guyer Annual summary of vital statistics: 2006 Pediatrics 121 2008 788 801
15. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr, and C.B. Granger Decline in rates of death and heart failure in acute coronary syndromes. 1999-2006 JAMA 297 2007 1892 1900 (Pubitemid 46707843)
16. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke Explaining the decreased in U.S deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398 (Pubitemid 46883773)
17. S.L. Hardoon, P.H. Whincup, L.T. Lennon, S.G. Wannamethee, S. Capewell, and R.W. Morris How much of the recent decline in the incidence of myocardial infarction in british men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study Circulation 117 2008 598 604
18. D.K. Foot, R.P. Lewis, T.A. Pearson, and G.A. Beller Demographics and cardiology, 1950-2050 J Am Coll Cardiol 35 Suppl B 2000 B66 B80
19. A.R. Davies, L. Smeeth, and E.M. Grundy Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005 Eur Heart J 28 2007 2142 2147 (Pubitemid 47517445)
20. K.S. Reddy Cardiovascular disease in non-Western countries N Engl J Med 350 2004 2438 2440 (Pubitemid 38736540)
21. S. Yusuf, S. Reddy, S. Ounpuu, and S. Anand Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulotion 104 2001 2746 2753 (Pubitemid 33108145)
22. S. Yusuf, S. Reddy, S. Ounpuu, and S. Anand Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies Circulation 104 2001 2855 2864 (Pubitemid 33126663)
23. Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, and A. Caspi Prevalence and significance of unrecognized renal insufficiency in patients with heart failure Eur Heart J 29 2008 1029 1036 (Pubitemid 351844687)
24. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 2005 937 954 (Pubitemid 41316498)
25. E. Shantsila, T. Watson, and G.Y. Lip Endothelial progenitor cells in cardiovascular disorders J Am Coll Cardiol 49 2007 741 752 (Pubitemid 46251466)
26. K.A. Moore, and I.R. Lemischka Stem cells and their niches Science 311 2006 1880 1885
27. E. Adler, Z.A. Fayad, S. Kattman, and G. Keller Submitted 2008
28. Adler E, Fayad ZA, Kattman S, Keller G. Submitted. 2008.
29. V. Fuster, Z.A. Fayad, P.R. Moreno, M. Poon, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging J Am Coll Cardiol 46 2005 1209 1218 (Pubitemid 41615539)
30. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349:1857-63.
31. I. Giatras, J. Lau, and A.S. Levey Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a metaanalysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group Ann Intern Med 127 1997 337 345
32. S. Dellegrottaglie, R. Saran, B. Gillespie, X. Zhang, S. Chung, and F. Finkelstein Prevalence and predictors of cardiovascular calcium in chronic kidney disease (from the Prospective Longitudinal RRI-CKD Study) Am J Cardiol 98 2006 571 576 (Pubitemid 44233449)
33. J. Shepherd, J.P. John, J.J.P Kastelein, V. Vera Bittner, P. Deedwania, A. Breazna, S. Dobson, D.J. Wilson, A. Zuckerman, N.K. Wenger For the Treating to New Targets Investigators Intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease and chronic kidney disease: The Treating to New Targets (TNT) study J Am Coll Cardiol 51 2008 1448 1454
34. U. Baber, R.D. Toto, and J.A. De Lemos Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure Am Heart J 153 2007 471 477 (Pubitemid 46440694)
35. C. Wanner, V. Krane, W. Marz, M. Olschewski, J.F. Mann, and G. Ruf Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
36. V. Fuster, R.A. Walsh, R.A. O'Rourke, and P. Poole-Wilson Hurst's The heart 11.a ed. 2008 McGraw-Hill New York
37. J.D. Sachs, and J.W. McArthur The Millennium Project: a plan for meeting the Millennium Development Goals Lancet 365 2005 347 353 (Pubitemid 40139114)
38. V. Fuster, J. Voute, M. Hunn, and S.C. Smith Jr Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern Circulation 116 2007 1966 1970 (Pubitemid 350287092)